Stay updated on Cabozantinib in Solid Tumors & HIV Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Solid Tumors & HIV Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-06T19:50:54.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, replacing the usual study content. This indicates the record is unavailable and users are shown a link to the homepage.
    Difference
    22%
    Check dated 2026-09-22T22:08:54.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's Revision tag updated from v3.6.6 to v3.7.0, indicating an update to the page template/version used for this study record.
    Difference
    0.0%
    Check dated 2026-09-15T20:51:16.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.5 to v3.6.6, indicating an internal update to the ClinicalTrials.gov page. This does not modify any study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-09-01T19:37:21.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page footer revision tag updated from v3.6.4 to v3.6.5. This change reflects a version update on the site and does not alter the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-11T08:47:42.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    This is a minor site update with the revision tag changing from v3.6.3 to v3.6.4. It does not modify study data, eligibility criteria, or other user-facing content on the page.
    Difference
    0.0%
    Check dated 2026-07-28T05:10:22.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Solid Tumors & HIV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Solid Tumors & HIV Clinical Trial page.